Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/NEUROSENSE-THERAPEUTICS-L-130483704/nieuws/NeuroSense-Therapeutics-Ltd-Voltooit-de-dosering-van-de-laatste-patient-in-het-dubbelblinde-segmen-45300509/?utm_source=whatsapp&utm_medium=social&utm_campaign=share